|
Volumn 23, Issue 2-4, 2000, Pages 213-218
|
Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBRINOLYTIC AGENT;
HERBACEOUS AGENT;
LUMBROKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANTICOAGULATION;
BLOOD SAMPLING;
BRAIN INFARCTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME INHIBITION;
FEMALE;
FIBRIN CLOT;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PARTIAL THROMBOPLASTIN TIME;
PROTHROMBIN TIME;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
AGED;
AGED, 80 AND OVER;
BLOOD COAGULATION;
BLOOD COAGULATION TESTS;
CEREBRAL INFARCTION;
ENDOPEPTIDASES;
FEMALE;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
FIBRINOGEN;
FIBRINOLYTIC AGENTS;
HUMANS;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
SINGLE-BLIND METHOD;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
VON WILLEBRAND FACTOR;
|
EID: 0034456729
PISSN: 13860291
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (54)
|
References (9)
|